Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00433355 · ClinicalTrials.gov registry record
Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome
A clinical trial of Chronic Fatigue Syndrome, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT00433355 is a study of Chronic Fatigue Syndrome that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 15 participants, below the 7,247-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00433355, a study of Chronic Fatigue Syndrome, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand what causes a continuing fatigue for a long time with a number of symptoms occurring at the same time (Chronic Fatigue Syndrome-CFS). Epstein Barr Virus is among the group of viruses that have been associated with a continuing fatigue for a long time with a number of symptoms occurring at the same time, but the cause is still unknown.
Conditions Studied
Study Locations (1)
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00433355
The ClinicalTrials.gov registry entry for NCT00433355 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,247-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (100% lower). The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Fatigue Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00433355 reports 1 study location spanning 1 distinct geographic area - top geographies include Mississippi.
Frequently Asked Questions
What is clinical trial NCT00433355 about?
NCT00433355 is a clinical study titled "Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome". The purpose of this study is to understand what causes a continuing fatigue for a long time with a number of symptoms occurring at the same time (Chronic Fatigue Syndrome-CFS). Epstein Barr Virus is among the group of viruses that have been associated with a continuing fatigue for a long time with a...
What is the current status of trial NCT00433355?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2007-01. Estimated completion is 2008-10.
What conditions does trial NCT00433355 study?
This clinical trial studies the following conditions: Chronic Fatigue Syndrome.
Who is sponsoring clinical trial NCT00433355?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00433355 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Fatigue Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
RECRUITING · Phase 1
-
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
RECRUITING · Phase 2
-
Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
RECRUITING · NA
-
tVNS in Long COVID-19
RECRUITING · NA
-
The Long COVID-19 Wearable Device Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.